Remdesivir, an investigational drug developed by Gilead Sciences Inc. as a general purpose anti-viral, is being billed as the most promising Covid-19 drug by researchers. Andrew Joseph is a reporter at STAT covering health and medicine who has been looking into Remdesivir, which is claimed to have aided the first confirmed U.S. coronavirus patient.
29 Mar 2020
Remdesivir looms as most likely Covid-19 drug
From Sunday Morning, 8:47 am on 29 March 2020
Tags:
To embed this content on your own webpage, cut and paste the following:
See terms of use.